JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for MERSENNE Archives


MERSENNE Archives

MERSENNE Archives


MERSENNE@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

MERSENNE Home

MERSENNE Home

MERSENNE  April 2009

MERSENNE April 2009

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

CFP: Drugs, Standards, & Chronic Illness; Manchester 27-28 Nov 2009

From:

Carsten Timmermann <[log in to unmask]>

Reply-To:

Carsten Timmermann <[log in to unmask]>

Date:

Mon, 6 Apr 2009 11:12:02 +0100

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (84 lines)

Call for Papers
New deadline: 8 May 2009

DRUGS, STANDARDS, AND CHRONIC ILLNESS

Workshop
To be held at the
Centre for the History of Science, Technology and Medicine
University of Manchester
27-28 November 2009

Non-communicable illnesses such as cancer or heart disease have long 
been feared. Having previously been conceived of as ‘diseases of 
civilization’ or ‘degenerative diseases’, in the twentieth century, when 
the threats posed especially by tuberculosis declined in the 
industrialised world, these illnesses turned into major issues for 
policy makers and public health experts, pharmaceutical companies and an 
anxious public. Cancer and cardiovascular disease and the role that the 
development and marketing of treatments for chronic illness have played 
in the broader history of standardization in medicine will be the 
central theme of this workshop.

The histories of cancer, cardiovascular disease and other 
non-communicable illnesses have much in common, but there are important 
differences between them that are worth exploring. Many of the 
blockbuster drugs of the last 50 years have been developed for the 
treatment of cardiovascular disorders. In the course of this 
development, some illnesses have been transformed from acute to chronic 
(e.g. malignant hypertension) and it has become acceptable to treat 
physiological parameters that do not cause symptoms but are 
statistically associated with illness later in life (e.g. mild 
hypertension or hypercholesterolaemia). In contrast, and with few 
exceptions, cancer drugs have often been used to treat what might 
otherwise be considered as orphan diseases and have rarely been as 
commercially profitable as cardiovascular drugs. Nevertheless, cancer 
has been central to the development of many of the practices, such as 
testing, clinical research, and standardization, which are increasingly 
applied to other fields of medicine, above all the multi-centre 
randomised clinical trial.

We are especially interested in contributions that are in themselves 
comparative or invite comparisons, between different illnesses (for 
example heart disease and cancer) or across different national contexts.

Papers may discuss issues surrounding notions of the chronic and the 
acute or the relationship between risk and disease. Or they may look at 
spaces of drug administration: from inpatient to outpatient departments. 
Institutional developments will also have to be discussed. Another issue 
worth exploring is the concept of ‘chemotherapy’. What did it mean in 
different contexts? Regulatory institutions, policies and practices also 
lend themselves to international comparisons. Such practices were 
closely related to the clinical specialties dealing with the different 
diseases, inviting comparisons between them. Further points for 
discussion will be issues related to the consumption of medicines, the 
role of patients and patient organizations, and questions of gender. All 
these can be viewed as leading to the establishment of standards that 
were different between countries and diseases, in a process that can be 
studied historically and geographically.

We plan to organise the workshop around the following main analytical 
points:
- The management of risk and efficacy
- The structure of biomedical research: laboratories, clinics, protocols
- Market conceptualisation, market realities, sales and uses
- Regulatory frameworks and regulatory practices

Please send abstracts (no more than 500 words) to
Dr Carsten Timmermann: [log in to unmask] and
Dr Viviane Quirke: [log in to unmask]

New deadline for abstracts: 8 May 2009

The workshop forms part of the Research Networking Programme 'Standard 
Drugs and Drug Standards' of the European Science Foundation. For more 
information please visit http://drughistory.eu/

-- 
Carsten Timmermann, PhD
Centre for the History of Science, Technology and Medicine
The University of Manchester, Simon Building, Room 2.36
Manchester M13 9PL, United Kingdom
Phone +44-(0)161-275 7950  Fax +44-(0)161-275 5699
http://www.manchester.ac.uk/chstm
http://www.cancer-history.org

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


WWW.JISCMAIL.AC.UK

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager